Myasthenic Crisis Demanding Mechanical Ventilation
Neurol 94:e299-e313, Neumann, B.,et al, 2020
International Consensus Guidance for Management of Myasthenia Gravis
Neurol 87:419-425, Sanders, D.B.,et al, 2016
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Comparative Analysis of Therapeutic Options Used for Myasthenia Gravis
Ann Neurol 68:797-805, Mandawat,A.,et al, 2010
Incidence and Mortality Rates of Myasthenia Gravis and Myasthenic Crisis in US Hospitals
Neurol 72:1548-1554, Alshekhlee,A.,et al, 2009
Plasma Exchange Versus Intravenous Immunoglobulin Treatment in Myasthenic Crisis
Neurol 52:629-632, Qureshi,A.I.,et al, 1999
Clinical Trial of Plasma Exchange and High-dose Intravenous Immunoglobulin in Myasthenia Gravis
Ann Neurol 41:789-796, Gajdos,P.,et al, 1997
Intensive Care of the Myasthenic Patient
Neurol 48 (Suppl 5) :S70-S75997., Mayer,S.A., 1997
Myasthenic Crisis:Clinical Features, Mortality, Comp, & Risk Factors for Prolonged Intubation
Neurol 48:1253-1254, Thomas,C.E.,et al, 1997
Myasthenic Crisis Response to Plasmapheresis Following Failure of Intravenous Gammaglobulin
Arch Neurol 50:837-840, Stricker,R.B.,et al, 1993
Myasthenia Gravis in Mothers and Their Newborns
Clin Obstet Gynecol 34:82-99, Plauche,W.C., 1991
Aggravation of Human and Experimental Myasthenia Gravis by Contrast Media
Neurol 40:1623-1625, Eliashiv,S.,et al, 1990
Plasmapheresis for Myasthenic Crisis in a Young Child
J Pediatr 110:740-742, Snead,O.C.III.,et al, 1987
Myasthenic Crisis after Intravenous Administration of Iodinated Contrast Agent
Neurol 35:1219-1220, Chagnac,Y.,et al, 1985
Ventilatory Failure in Myasthenia Gravis
JNNP 45:217-222, Ferguson,I.T.,et al, 1982
Heat-Induced Myasthenic Crisis
Arch Neurol 37:671-672, Gutmann,L., 1980
Controversies About the Treatment of Myasthenia Gravis
JNNP 43:644-659, Rowland,L.P., 1980
Heat-Induced Myasthenic Crisis
Arch Neurol 37:671-672, Gutmann,L.,, 1980
Treatment of Myasthenia II
BMJ 213, 1971 April., , 1971
Diseases of Muscles-Clinical Manifestations & Differential Diagnosis
The New Physic 263, 1967, Oct., Boshes,L., 1967
Drug Therapy in Myasthenia Gravis
Mod Med 286, Sept1965., Johns,R., 1965
Clinicopathologic Conference, Posterior Reversible Encephalopathy Syndrome Due to Sickle Cell Disease
NEJM 392:268-276, Case 2-2025, 2025
Severe Myotonic Crisis Resembling Malignant Hyperthermia
Neurol 104:e213497, Wadhwani,A.R.,et al, 2025
Sarcoidosis of the Pituitary Gland and Stalk in a Man Presenting Asthenia, Impotence, Loss of Libido, Polyuria, and Polydipsia
Lancet 404:2460-2461, Clement,J., et al, 2024
Distribution of Silent Cerebral Infarcts in Adults with Sickle Cell Disease
Neurol 102:e209247, Jones,R.S.,et al, 2024
Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023
A Case of Acute Akinetic Mutism and Encephalopathy
Neurol 99:761-766, Jain, V.,et al, 2022
Intracranial MRI Vessel-Wall Imaging
Pract Neurol March-April:61-65, Barnes,M.,& Moftakhar,P., 2021
A 68-Year-Old Man with Proximal Weakness and Seizures
Neurol 97:e423-e428, Chen, T., 2021
Catastrophic Cerebral Fat Embolism Syndrome Lacks Hyperacute MRI Findings
Neurol: Clin Pract 6:e962-e964, Gusler, M.T.,et al, 2021
Fat Embolism Syndrome in Sickle Cell Disease
J Clin Med 9:1-12, Tsitsikas, D.A.,et al, 2020
Vessel Wall MR Imaging for the Detection of Intracranial Inflammatory Vasculopathies
Cardiovasc Diagn Ther 10:1108-1119, Edjlali,M.,et al, 2020
Long-Term Follow-Up, Quality of Life, and Survival of Patients with Lambert-Eaton Myasthenic Syndrome
Neurol 94:e511-e520, Lipka, A.F.,et al, 2020
Myasthenia Gravis Following Dabrafenib and Trametinib for Metastatic Melanoma
Neurol 94:322-323, Zaloum, A.,et al, 2020
Neurological Impairments in a Patient Returning from Cuba
JAMA Neurol 77:1570-1571, Serlin, Y.,et al, 2020
A 47-year-old Man with Diffuse White Matter Disease and Rapidly Progressive Dementia
Neurol 92:e2832-e2837, Di Luca, D.G.,et al, 2019
Drug Approved for Rare Muscle Weakening Syndrome
JAMA 321:239, Voelker, R., 2019
Management of Stroke in Neonates and Children
Stroke 50:e51-e96, Ferriero, D.M.,et al, 2019
Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019
Pembrolizumab-Induced Myasthenia Gravis
Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018
Congenital Myasthenic Syndromes in Adult Neurology Clinic
Neurol 91:e1770-e1777, Kao, J.C.,et al, 2018
Acute demyelinating polyneuropathy induced by nivolumab
JNNP 89:435-437, Fukumoto, Y.,et al, 2018
A Child with Arthrogryposis
Neurol 91:e995-e998, Irumudomom, O. & Ghosh, P.S., 2018
Myasthenia Gravis Following Alemtuzumab Therapy for Multiple Sclerosis
Neurol 91:622-624, Midaglia, L.,et al, 2018
Bilateral Cavernous Carotid Aneurysms: Atypical Presentation of a Rare Cause of Mass Effect
Front Neurol doi:10.3389/fneur.2018.0069, Gagliardi, D.,et al, 2018
Numb Chin Syndrome
UptoDate.com Sept, Robertson, C.E., 2018
Cerebral Fat Embolism Syndrome in Sickle Cell Disease Without Evidence of Shunt
eNeurologicSci 14:19-20, Nathan, C.L.,et al, 2018
Neurological Complications of Sickle Cell Disease
Eur Hematol Assoc 11:206-209, Kirkham,F.J., 2017
Uncommon Causes of Cerebral Microbleeds
J Stroke Cerebrovasc Dis 26:2043-2049, Noorbakhsh-Sabet, N.,et al, 2017